Advancing cardiovascular equity requires a continuous cycle: understanding → action → impact, across the entire care continuum. @accintouch.bsky.social is well positioned to help drive this forward. https://bit.ly/4zlKvX3
#JACC #ACCPresident #HealthEquity #HealthDisparities
#JACC #ACCPresident #HealthEquity #HealthDisparities
November 6, 2026 at 7:53 PM
Advancing cardiovascular equity requires a continuous cycle: understanding → action → impact, across the entire care continuum. @accintouch.bsky.social is well positioned to help drive this forward. https://bit.ly/4zlKvX3
#JACC #ACCPresident #HealthEquity #HealthDisparities
#JACC #ACCPresident #HealthEquity #HealthDisparities
Jacc - when feeling masculine
Jacci - the default, kinda androgynous
Jaccipit - used on government paperwork or when he's in trouble so his mom calls him by his full name
Jacci - the default, kinda androgynous
Jaccipit - used on government paperwork or when he's in trouble so his mom calls him by his full name
November 1, 2026 at 6:55 PM
Jacc - when feeling masculine
Jacci - the default, kinda androgynous
Jaccipit - used on government paperwork or when he's in trouble so his mom calls him by his full name
Jacci - the default, kinda androgynous
Jaccipit - used on government paperwork or when he's in trouble so his mom calls him by his full name
Congratulations to our student journalists with the Citrus College Clarion who picked up 10 awards during the Journalism Association of Community Colleges (JACC) SoCal Regional Conference at CSUN in October!
news.citruscollege.edu/news/clarion...
news.citruscollege.edu/news/clarion...
November 5, 2026 at 4:48 PM
Congratulations to our student journalists with the Citrus College Clarion who picked up 10 awards during the Journalism Association of Community Colleges (JACC) SoCal Regional Conference at CSUN in October!
news.citruscollege.edu/news/clarion...
news.citruscollege.edu/news/clarion...
JACC Advances: #LAAO (Watchman/Amulet) showed no superiority over DOACs for stroke/SE/CV death or major bleeding. #DOAC #metaanalysis www.jacc.org/doi/10.1016/...
Left Atrial Appendage Occlusion vs Direct Oral Anticoagulants for Atrial Fibrillation: Network Meta-Analyses
www.jacc.org
November 4, 2026 at 11:18 AM
JACC Advances: #LAAO (Watchman/Amulet) showed no superiority over DOACs for stroke/SE/CV death or major bleeding. #DOAC #metaanalysis www.jacc.org/doi/10.1016/...
SINGLE-CLOSURE: A single-ProGlide strategy may be noninferior for a composite of access-site or access-related vascular complications compared to conventional double-ProGlide closure following transfemoral #TAVR.
https://bit.ly/4A1AZZy #JACC #TCT2026 #CardioSky @crfheart.bsky.social
https://bit.ly/4A1AZZy #JACC #TCT2026 #CardioSky @crfheart.bsky.social
November 3, 2026 at 8:09 PM
SINGLE-CLOSURE: A single-ProGlide strategy may be noninferior for a composite of access-site or access-related vascular complications compared to conventional double-ProGlide closure following transfemoral #TAVR.
https://bit.ly/4A1AZZy #JACC #TCT2026 #CardioSky @crfheart.bsky.social
https://bit.ly/4A1AZZy #JACC #TCT2026 #CardioSky @crfheart.bsky.social
Angiography-derived vFFR-guided revascularization met the prespecified absolute criterion for noninferiority to wire-based FFR, according to results from the LIPSIA-STRATEGY trial presented at #TCT2026 and simultaneously published in #JACC. 🔗 https://bit.ly/4szDdNj
@crfheart.bsky.social
@crfheart.bsky.social
November 2, 2026 at 11:55 PM
Angiography-derived vFFR-guided revascularization met the prespecified absolute criterion for noninferiority to wire-based FFR, according to results from the LIPSIA-STRATEGY trial presented at #TCT2026 and simultaneously published in #JACC. 🔗 https://bit.ly/4szDdNj
@crfheart.bsky.social
@crfheart.bsky.social
#TCT2026: The JENA-VAD study simultaneously published in #JACC sheds early light on #TAVR using the Trilogy transcatheter heart valve for left ventricular assist device (LVAD)-associated aortic regurgitation.
Read more: https://bit.ly/4zmCQs3
@crfheart.bsky.social #CardioSky
Read more: https://bit.ly/4zmCQs3
@crfheart.bsky.social #CardioSky
November 3, 2026 at 10:00 PM
#TCT2026: The JENA-VAD study simultaneously published in #JACC sheds early light on #TAVR using the Trilogy transcatheter heart valve for left ventricular assist device (LVAD)-associated aortic regurgitation.
Read more: https://bit.ly/4zmCQs3
@crfheart.bsky.social #CardioSky
Read more: https://bit.ly/4zmCQs3
@crfheart.bsky.social #CardioSky
ENCIRCLE: Patients with symptomatic mitral regurgitation (MR) who underwent full percutaneous transseptal #TMVR continued to see durable near #vhdMR elimination & sustained improvements in functional & health status outcomes at 2 years. https://bit.ly/4z2BMIW
#JACC #CardioSky @crfheart.bsky.social
#JACC #CardioSky @crfheart.bsky.social
November 3, 2026 at 9:25 PM
ENCIRCLE: Patients with symptomatic mitral regurgitation (MR) who underwent full percutaneous transseptal #TMVR continued to see durable near #vhdMR elimination & sustained improvements in functional & health status outcomes at 2 years. https://bit.ly/4z2BMIW
#JACC #CardioSky @crfheart.bsky.social
#JACC #CardioSky @crfheart.bsky.social
It takes a village. A combined medical effort with community and family leadership focused on household diets, home monitoring, exercise, and treatment dropped SBP by > 10 mmHg more than usual care: https://bit.ly/4eiuWHU
#JACC #cvPrev #hypertension
#JACC #cvPrev #hypertension
November 3, 2026 at 6:05 PM
It takes a village. A combined medical effort with community and family leadership focused on household diets, home monitoring, exercise, and treatment dropped SBP by > 10 mmHg more than usual care: https://bit.ly/4eiuWHU
#JACC #cvPrev #hypertension
#JACC #cvPrev #hypertension
📹 In this Quick Takes video, Rasha Al-Lamee, MD, & Josep Rodés-Cabau, MD, PhD, discuss findings from the ANDES trial. The study evaluated the clinical outcomes & device-related thrombosis events at 1-year follow-up.
Get full details ➡️ https://bit.ly/4krXtyr
#TCT2026 #JACC @crfheart.bsky.social
Get full details ➡️ https://bit.ly/4krXtyr
#TCT2026 #JACC @crfheart.bsky.social
November 1, 2026 at 4:20 PM
📹 In this Quick Takes video, Rasha Al-Lamee, MD, & Josep Rodés-Cabau, MD, PhD, discuss findings from the ANDES trial. The study evaluated the clinical outcomes & device-related thrombosis events at 1-year follow-up.
Get full details ➡️ https://bit.ly/4krXtyr
#TCT2026 #JACC @crfheart.bsky.social
Get full details ➡️ https://bit.ly/4krXtyr
#TCT2026 #JACC @crfheart.bsky.social
Hear from Drs. John A. Spertus, Rasha Al-Lamee, & John Bittl as they discuss the highlights from Day 2️⃣ of #TCT2026 & preview what's ahead on Day 3️⃣, including the simultaneous publication of LBCTs in #JACC!
Stay tuned for more insights 👉 https://bit.ly/4A4utBk @crfheart.bsky.social #CardioSky
Stay tuned for more insights 👉 https://bit.ly/4A4utBk @crfheart.bsky.social #CardioSky
November 2, 2026 at 5:23 PM
Hear from Drs. John A. Spertus, Rasha Al-Lamee, & John Bittl as they discuss the highlights from Day 2️⃣ of #TCT2026 & preview what's ahead on Day 3️⃣, including the simultaneous publication of LBCTs in #JACC!
Stay tuned for more insights 👉 https://bit.ly/4A4utBk @crfheart.bsky.social #CardioSky
Stay tuned for more insights 👉 https://bit.ly/4A4utBk @crfheart.bsky.social #CardioSky
ICYMI: Dive into the latest paper published in #JACC that reveals how #CVD mortality varies dramatically across U.S. counties, racial & ethnic groups, & specific CV conditions.
Discover the data driving the future of CV #HealthEquity 👉 https://bit.ly/3UaTkUO
#GBDStudy #CardioSky
Discover the data driving the future of CV #HealthEquity 👉 https://bit.ly/3UaTkUO
#GBDStudy #CardioSky
October 31, 2026 at 9:24 PM
ICYMI: Dive into the latest paper published in #JACC that reveals how #CVD mortality varies dramatically across U.S. counties, racial & ethnic groups, & specific CV conditions.
Discover the data driving the future of CV #HealthEquity 👉 https://bit.ly/3UaTkUO
#GBDStudy #CardioSky
Discover the data driving the future of CV #HealthEquity 👉 https://bit.ly/3UaTkUO
#GBDStudy #CardioSky
potentially making the country a primary entertainment hub in the Gulf long before the construction of modern venues like The Arena Kuwait (near the 360 Mall) or the Sheikh Jaber Al-Ahmad Cultural Centre (JACC)/Opera House.
(End)
(End)
November 5, 2026 at 7:55 PM
potentially making the country a primary entertainment hub in the Gulf long before the construction of modern venues like The Arena Kuwait (near the 360 Mall) or the Sheikh Jaber Al-Ahmad Cultural Centre (JACC)/Opera House.
(End)
(End)
New from #NephFellow Dr DeMis and colleagues in JACC Case Reports
Right Atrial Cardiac Fibroma Mimicking Eustachian Valve Endocarditis in Neutropenic Sepsis: A Diagnostic Challenge
https://pubmed.ncbi.nlm.nih.gov/42969912/
Right Atrial Cardiac Fibroma Mimicking Eustachian Valve Endocarditis in Neutropenic Sepsis: A Diagnostic Challenge
https://pubmed.ncbi.nlm.nih.gov/42969912/
November 3, 2026 at 10:47 PM
New from #NephFellow Dr DeMis and colleagues in JACC Case Reports
Right Atrial Cardiac Fibroma Mimicking Eustachian Valve Endocarditis in Neutropenic Sepsis: A Diagnostic Challenge
https://pubmed.ncbi.nlm.nih.gov/42969912/
Right Atrial Cardiac Fibroma Mimicking Eustachian Valve Endocarditis in Neutropenic Sepsis: A Diagnostic Challenge
https://pubmed.ncbi.nlm.nih.gov/42969912/
Young adults who exclusively vape exhibit significantly higher systolic and diastolic blood pressure compared with individuals who have never smoked or vaped.
Long-term vaping increases blood pressure (BP) relative to never vaping or smoking, (JACC: Advances).
Long-term vaping increases blood pressure (BP) relative to never vaping or smoking, (JACC: Advances).
November 5, 2026 at 1:18 AM
Young adults who exclusively vape exhibit significantly higher systolic and diastolic blood pressure compared with individuals who have never smoked or vaped.
Long-term vaping increases blood pressure (BP) relative to never vaping or smoking, (JACC: Advances).
Long-term vaping increases blood pressure (BP) relative to never vaping or smoking, (JACC: Advances).
When a multifaceted CV intervention works, which part is the heavy lifter? In CRHCP, BP improvement drove 67.5% of the observed benefit, while behavioral and metabolic gains added smaller contributions.
New research in #JACC: https://bit.ly/4eg7IlG
#Hypertension #PopulationHealth
New research in #JACC: https://bit.ly/4eg7IlG
#Hypertension #PopulationHealth
November 4, 2026 at 6:06 PM
When a multifaceted CV intervention works, which part is the heavy lifter? In CRHCP, BP improvement drove 67.5% of the observed benefit, while behavioral and metabolic gains added smaller contributions.
New research in #JACC: https://bit.ly/4eg7IlG
#Hypertension #PopulationHealth
New research in #JACC: https://bit.ly/4eg7IlG
#Hypertension #PopulationHealth
5. Cocoa Room (JACC/Opera House)
4. Madison & Heig (Bneid Al-Gar, Gulf Road)
🥉. Concrete DT (Kuwait City)
🥈. Brian’s Brekkie (also in Kuwait City)
🥇. Lazy Cat (Murouj)
4. Madison & Heig (Bneid Al-Gar, Gulf Road)
🥉. Concrete DT (Kuwait City)
🥈. Brian’s Brekkie (also in Kuwait City)
🥇. Lazy Cat (Murouj)
November 3, 2026 at 10:53 AM
5. Cocoa Room (JACC/Opera House)
4. Madison & Heig (Bneid Al-Gar, Gulf Road)
🥉. Concrete DT (Kuwait City)
🥈. Brian’s Brekkie (also in Kuwait City)
🥇. Lazy Cat (Murouj)
4. Madison & Heig (Bneid Al-Gar, Gulf Road)
🥉. Concrete DT (Kuwait City)
🥈. Brian’s Brekkie (also in Kuwait City)
🥇. Lazy Cat (Murouj)
SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization Than Paclitaxel-Coated Balloons in Femoropopliteal Disease
Late-breaking data presented at TCT 2026 and published simultaneously in JACC: Cardiovascular Interventions show durable benefit with…
Late-breaking data presented at TCT 2026 and published simultaneously in JACC: Cardiovascular Interventions show durable benefit with…
SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization Than Paclitaxel-Coated Balloons in Femoropopliteal Disease
Late-breaking data presented at TCT 2026 and published simultaneously in JACC: Cardiovascular Interventions show durable benefit with MagicTouch PTA, with similar walking capacity, quality of life…
news-area.com
November 3, 2026 at 11:59 PM
SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization Than Paclitaxel-Coated Balloons in Femoropopliteal Disease
Late-breaking data presented at TCT 2026 and published simultaneously in JACC: Cardiovascular Interventions show durable benefit with…
Late-breaking data presented at TCT 2026 and published simultaneously in JACC: Cardiovascular Interventions show durable benefit with…
PREMIUM Trial: ARC-HBR identified patients with a substantially higher overall risk after primary #PCI for #STEMI but did not identify a subgroup with a more favorable treatment effect of upfront aspirin omission. https://bit.ly/4A3N3JM
#JACC #TCT2026 @crfheart.bsky.social
#JACC #TCT2026 @crfheart.bsky.social
November 1, 2026 at 6:00 PM
PREMIUM Trial: ARC-HBR identified patients with a substantially higher overall risk after primary #PCI for #STEMI but did not identify a subgroup with a more favorable treatment effect of upfront aspirin omission. https://bit.ly/4A3N3JM
#JACC #TCT2026 @crfheart.bsky.social
#JACC #TCT2026 @crfheart.bsky.social
🌟 The latest from #TCT2026: New data from VERITAS are here.
🎯 Get the key takeaways below.
📖 The full findings are simultaneously published in JACC: Interventions.
🎯 Get the key takeaways below.
📖 The full findings are simultaneously published in JACC: Interventions.
November 2, 2026 at 6:03 AM
🌟 The latest from #TCT2026: New data from VERITAS are here.
🎯 Get the key takeaways below.
📖 The full findings are simultaneously published in JACC: Interventions.
🎯 Get the key takeaways below.
📖 The full findings are simultaneously published in JACC: Interventions.
journals are drifting the other way though. per Science, the JACC journals stopped requiring disclosure of AI writing help last year, and PLOS no longer asks about common uses like language improvements. authors stay accountable for the content instead
In know this is an unpopular take because inequality etc but I truly think that, if you submit a paper to a journal without disclosing that it was AI aided, you should be charged a fee by the journal for wasting other people's time.
I desk rejected a journal manuscript that left instructions from the AI agent to the author in the text. That's three minutes of my life that I'm not getting back.
November 2, 2026 at 7:42 PM
journals are drifting the other way though. per Science, the JACC journals stopped requiring disclosure of AI writing help last year, and PLOS no longer asks about common uses like language improvements. authors stay accountable for the content instead